Friday, June 27, 2025 6/27/2025

Gut microbiota-mediated fiber fermentation in HIV-associated cardiovascular disease

Award Number: DP1HL174182
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/15/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2029

Group Awards By:

View Award Description

Gut microbiota-mediated fiber fermentation in HIV-associated cardiovascular disease - PROJECT ABSTRACT: While antiretroviral therapy has significantly increased lifespan of people with HIV (PWH), heightened rates of cardiovascular comorbidities continue to occur in this population as compared to HIV-seronegative individuals. The mechanistic basis of this elevated cardiovascular disease (CVD) risk in PWH remains poorly understood and constitutes a barrier to devising effective treatments. Hypertension increases CVD risk and recent work has uncovered a role for gut microbial metabolism in modulating hypertension. The gut microbiota is significantly altered in antiretroviral-treated PWH, and the most robustly observed change in the HIV-associated gut microbiota is a depletion of microbes capable of metabolizing dietary fiber into short chain fatty acids (SCFAs). Prior work from outside the realm of HIV research suggests a depletion of SCFAs can cause increased blood pressure and consequently increase cardiovascular disease incidence. Whether the loss of gut microbial SCFA producers in PWH contributes to elevated cardiovascular disease risk remains an important but unexplored question. Through this Catalyst Award, I will test the impact of the HIV- associated gut microbiota on bioavailable SCFA production and investigate effects of fiber fermentation on hypertension and manifestations of cardiovascular disease using a combination of murine gnotobiotic and specific pathogen-free models, omics technologies, and computational biology. Mechanisms of host SCFA uptake and utilization as well as methods to augment SCFA production within the HIV-associated microbiota will be explored to identify pathways that can be targeted to alleviate hypertension in PWH. This high-risk series of studies have potential to elucidate mechanisms of CVD risk in PWH and identify microbiota-directed therapeutic modalities.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $551,000 )
2025	2025	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	WEST HOLLYWOOD	CA	90048	LOS ANGELES	USA	Cardiovascular Diseases Research	000	2	4/25/2025	NON-COMPETING CONTINUATION	$551,000
														Subtotal = $551,000

Issue Date FY: 2024 ( Subtotal = $551,000 )
2024	2024	CEDARS-SINAI MEDICAL CENTER	8700 BEVERLY BLVD	WEST HOLLYWOOD	CA	90048	LOS ANGELES	USA	Cardiovascular Diseases Research	000	1	4/8/2024	NEW	$551,000
														Subtotal = $551,000

Grand Total All Awards = $1,102,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Gut microbiota-mediated fiber fermentation in HIV-associated cardiovascular disease

Award Number: DP1HL174182

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/15/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer